<?xml version="1.0"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Tavricheskiy Mediko-Biologicheskiy Vestnik</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Tavricheskiy Mediko-Biologicheskiy Vestnik</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Таврический медико-биологический вестник</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2070-8092</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">53567</article-id>
   <article-id pub-id-type="doi">10.29039/2070-8092-2020-23-3-91-97</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Клинический случай</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Clinical observations</subject>
    </subj-group>
    <subj-group>
     <subject>Клинический случай</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">ASPECTS OF DIFFERENTIAL DIAGNOSIS OF ANTIPHOSPHOLIPID SYNDROME AND MULTIPLE SCLEROSIS. DESCRIPTION OF THE CLINICAL CASE</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>АСПЕКТЫ ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКИ АНТИФОСФОЛИПИДНОГО СИНДРОМА И РАССЕЯННОГО СКЛЕРОЗА</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Чуприна</surname>
       <given-names>Л. А.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Chuprina</surname>
       <given-names>L. A.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Полторак</surname>
       <given-names>М. С.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Poltorak</surname>
       <given-names>M. S.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Крымский Федеральный Университет им. В.И. Вернадского</institution>
     <country>RU</country>
    </aff>
    <aff>
     <institution xml:lang="en">V.I. Vernadsky Crimean Federal University</institution>
     <country>RU</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2022-10-19T15:57:05+03:00">
    <day>19</day>
    <month>10</month>
    <year>2022</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-10-19T15:57:05+03:00">
    <day>19</day>
    <month>10</month>
    <year>2022</year>
   </pub-date>
   <volume>23</volume>
   <issue>3</issue>
   <fpage>91</fpage>
   <lpage>97</lpage>
   <history>
    <date date-type="received" iso-8601-date="2022-10-19T00:00:00+03:00">
     <day>19</day>
     <month>10</month>
     <year>2022</year>
    </date>
   </history>
   <self-uri xlink:href="https://ma.cfuv.ru/site/page/show/docid/260962">https://ma.cfuv.ru/site/page/show/docid/260962</self-uri>
   <abstract xml:lang="ru">
    <p>Антифосфолипидный синдром может имитировать многие заболевания, одним из которых является рассеянный &#13;
склероз. В статье представлены основные аспекты дифференциальной диагностики антифосфолипидного синдрома и &#13;
рассеянного склероза, а также приведен собственный клинический случай.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Antiphospholipid syndrome can mimic many diseases, one of which is multiple sclerosis. The article presents the main aspects of differential diagnosis of antiphospholipid syndrome and multiple sclerosis, as well as its own clinical case.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>антифосфолипидный синдром</kwd>
    <kwd>рассеянный склероз</kwd>
    <kwd>дифференциальная диагностика</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>antiphospholipid syndrome</kwd>
    <kwd>multiple sclerosis</kwd>
    <kwd>differential diagnosis</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Насонов Е.  Л. Антифосфолипидный синдром. М.: Литтерра; 2004.</mixed-citation>
     <mixed-citation xml:lang="en">Nasonov E.  L. Antifosfolipidnyy sindrom. M.: Litterra; 2004.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Калашникова Л. А. Джамантаева Б. Д. Неврологические  проявления антифосфолипидного  синдрома, имитирующие рассеянный склероз. Нейрохирургия и неврология  Казахстана. 2015;1(38):15-23.</mixed-citation>
     <mixed-citation xml:lang="en">Kalashnikova L. A. Dzhamantaeva B. D. Nevrologicheskie  proyavleniya antifosfolipidnogo  sindroma, imitiruyuschie rasseyannyy skleroz. Neyrohirurgiya i nevrologiya  Kazahstana. 2015;1(38):15-23.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ferreira S., D’Cruz D. P., Hughes DRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford). 2005;44(4):434-42. doi: 10.1093/rheumatology/keh532</mixed-citation>
     <mixed-citation xml:lang="en">Ferreira S., D’Cruz D. P., Hughes DRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford). 2005;44(4):434-42. doi: 10.1093/rheumatology/keh532</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Roussel V., Jaubertau M. O., Couderq C., e.a. Prevalence and clinical significance of antiphospholipid antibodies in multiple sclerosis: a study of 89 patients. J  Autoimmun  2000;  14:259-265.  doi:  10.1006/ jaut.2000.0367</mixed-citation>
     <mixed-citation xml:lang="en">Roussel V., Jaubertau M. O., Couderq C., e.a. Prevalence and clinical significance of antiphospholipid antibodies in multiple sclerosis: a study of 89 patients. J  Autoimmun  2000;  14:259-265.  doi:  10.1006/ jaut.2000.0367</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Stosic  M.,  Ambrus  J.,  Garg  N.,  Weinstock- Guttman B., Ramanathan M., Kalman B.., Minagar A., Munschauer F. E., Galey T. M., Hussein S., Bakshi R., Zivadinov R. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. J Neurol.  2009;257(1):63-71.  doi:10.1007/s00415-009- 5264-6</mixed-citation>
     <mixed-citation xml:lang="en">Stosic  M.,  Ambrus  J.,  Garg  N.,  Weinstock- Guttman B., Ramanathan M., Kalman B.., Minagar A., Munschauer F. E., Galey T. M., Hussein S., Bakshi R., Zivadinov R. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. J Neurol.  2009;257(1):63-71.  doi:10.1007/s00415-009- 5264-6</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cuadrado M. J., Khamashta M. A., Ballesteros A., Godfrey T., Simon M. J., Hughes GRV. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be  distinguished  from  multiple  sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore).  2000;79:57-68.  doi:10.1097/00005792- 200001000-00006</mixed-citation>
     <mixed-citation xml:lang="en">Cuadrado M. J., Khamashta M. A., Ballesteros A., Godfrey T., Simon M. J., Hughes GRV. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be  distinguished  from  multiple  sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore).  2000;79:57-68.  doi:10.1097/00005792- 200001000-00006</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Джамантаева  Б. Т. Первичный  антифосфолипидный  синдром,  имитирующий  рассеянный  склероз  (клиническое,  иммунологическое, нейрофизиологическое  и  нейровизуализационное  исследование): дис.  канд.мед.  наук.  М.:  2007. Доступно  по:  http://medical-diss.com/medicina/ pervichnyy-antifosfolipidnyy-sindrom-imitiruyuschiy- rasseyannyy-skleroz. Ссылка активна на 16.09.2020.</mixed-citation>
     <mixed-citation xml:lang="en">Dzhamantaeva  B. T. Pervichnyy  antifosfolipidnyy  sindrom,  imitiruyuschiy  rasseyannyy  skleroz  (klinicheskoe,  immunologicheskoe, neyrofiziologicheskoe  i  neyrovizualizacionnoe  issledovanie): dis.  kand.med.  nauk.  M.:  2007. Dostupno  po:  http://medical-diss.com/medicina/ pervichnyy-antifosfolipidnyy-sindrom-imitiruyuschiy- rasseyannyy-skleroz. Ssylka aktivna na 16.09.2020.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Гомоляко А. В., Новикова И. А. Антифосфолипидный синдром. Диагностика и лечение: учеб. пособие для студентов медицинских вузов. Гомель: учреждение  образования  «Гомельский  государственный  медицинский университет»; 2013.</mixed-citation>
     <mixed-citation xml:lang="en">Gomolyako A. V., Novikova I. A. Antifosfolipidnyy sindrom. Diagnostika i lechenie: ucheb. posobie dlya studentov medicinskih vuzov. Gomel': uchrezhdenie  obrazovaniya  «Gomel'skiy  gosudarstvennyy  medicinskiy universitet»; 2013.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Калашникова  Л.  А.  Неврология  антифосфолипидного синдрома. М. Медицина; 2003.</mixed-citation>
     <mixed-citation xml:lang="en">Kalashnikova  L.  A.  Nevrologiya  antifosfolipidnogo sindroma. M. Medicina; 2003.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Решетняк Т. М. Клинические рекомендации по лечению антифосфолипидного синдрома. М.; 2013.</mixed-citation>
     <mixed-citation xml:lang="en">Reshetnyak T. M. Klinicheskie rekomendacii po lecheniyu antifosfolipidnogo sindroma. M.; 2013.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rodrigues C., Carvalho, J., &amp; Shoenfeld, Y. Neurological  manifestations  of  antiphospholipid syndrome.  Eur  J  Clin  Invest  2010;40(4):350-359. doi:10.1111/j.1365-2362.2010.02263.x</mixed-citation>
     <mixed-citation xml:lang="en">Rodrigues C., Carvalho, J., &amp; Shoenfeld, Y. Neurological  manifestations  of  antiphospholipid syndrome.  Eur  J  Clin  Invest  2010;40(4):350-359. doi:10.1111/j.1365-2362.2010.02263.x</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Chapman J. The interface of multiple sclerosis and  antiphospholipid  antibodies.  Thrombosis  Res 2004;114:477-481. doi: 10.1016/j.thromres.2004.06.016</mixed-citation>
     <mixed-citation xml:lang="en">Chapman J. The interface of multiple sclerosis and  antiphospholipid  antibodies.  Thrombosis  Res 2004;114:477-481. doi: 10.1016/j.thromres.2004.06.016</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sicotte, N. L., Kaisey, M., Solomon, A. J., Luu, M., Giesser, B. S., Incidence of multiple sclerosis misdiagnosis  in  referrals  to  two  academic  centers. Multiple Sclerosis and Related Disorders. 2019;30:51- 56. doi:10.1016/j.msard.2019.01.048</mixed-citation>
     <mixed-citation xml:lang="en">Sicotte, N. L., Kaisey, M., Solomon, A. J., Luu, M., Giesser, B. S., Incidence of multiple sclerosis misdiagnosis  in  referrals  to  two  academic  centers. Multiple Sclerosis and Related Disorders. 2019;30:51- 56. doi:10.1016/j.msard.2019.01.048</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Digre, K. (2002). McDonald W. I., Compston A.,  Edan  G.  Recommended  diagnostic  criteria  for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Journal Of  Neuro-Ophthalmology.  2002;22(2):143.  doi: 10.1097/00041327-200206000-00041</mixed-citation>
     <mixed-citation xml:lang="en">Digre, K. (2002). McDonald W. I., Compston A.,  Edan  G.  Recommended  diagnostic  criteria  for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Journal Of  Neuro-Ophthalmology.  2002;22(2):143.  doi: 10.1097/00041327-200206000-00041</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Miyakis  S.,  Lockshin  M.,  Atsumi  T. International  consensus  statement  on  an  update  of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295- 306. doi: 10.1111/j.1538-7836.2006.01753.x</mixed-citation>
     <mixed-citation xml:lang="en">Miyakis  S.,  Lockshin  M.,  Atsumi  T. International  consensus  statement  on  an  update  of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295- 306. doi: 10.1111/j.1538-7836.2006.01753.x</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ijdo  I. J. W., Conti-Kelly A. M., Greco P. Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus. 1999;8:109-115.</mixed-citation>
     <mixed-citation xml:lang="en">Ijdo  I. J. W., Conti-Kelly A. M., Greco P. Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus. 1999;8:109-115.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">R  Cervera,  M-C  Boffa,  Khamashta  M. A.  and  GRV  Hughes.  The  Euro-Phospholipid project:  epidemiology  of  the  antiphospholipid syndrome  in  Europe.  Lupus.  2009;18:889-893.  doi: 10.1177/ 0961203309106832</mixed-citation>
     <mixed-citation xml:lang="en">R  Cervera,  M-C  Boffa,  Khamashta  M. A.  and  GRV  Hughes.  The  Euro-Phospholipid project:  epidemiology  of  the  antiphospholipid syndrome  in  Europe.  Lupus.  2009;18:889-893.  doi: 10.1177/ 0961203309106832</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Uthman I., Noureldine M., Berjawi A., Skaf M., Haydar A., Merashli M. &amp; Hughes G. Hughes syndrome and Multiple sclerosis. Lupus. 2014;24(2):115-121. doi: 10.1177/0961203314555539</mixed-citation>
     <mixed-citation xml:lang="en">Uthman I., Noureldine M., Berjawi A., Skaf M., Haydar A., Merashli M. &amp; Hughes G. Hughes syndrome and Multiple sclerosis. Lupus. 2014;24(2):115-121. doi: 10.1177/0961203314555539</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
